Year None20242023202220212020 01 Apr '2024 Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers 21 Mar '2024 Context Therapeutics Reports Full Year 2023 Operating and Financial Results
01 Apr '2024 Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers